Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,336 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Three-Dimensional Motor Nerve Organoid Generation.
Osaki T, Chow SYA, Nakanishi Y, Hernández J, Kawada J, Fujii T, Ikeuchi Y. Osaki T, et al. Among authors: nakanishi y. J Vis Exp. 2020 Sep 24;(163). doi: 10.3791/61544. J Vis Exp. 2020. PMID: 33044443
Modeling Axonal Degeneration Using Motor Nerve Organoids.
Chow SYA, Nakanishi Y, Kaneda S, Ikeuchi Y. Chow SYA, et al. Among authors: nakanishi y. Methods Mol Biol. 2022;2515:89-97. doi: 10.1007/978-1-0716-2409-8_6. Methods Mol Biol. 2022. PMID: 35776347
Quality control of protein synthesis in the early elongation stage.
Nagao A, Nakanishi Y, Yamaguchi Y, Mishina Y, Karoji M, Toya T, Fujita T, Iwasaki S, Miyauchi K, Sakaguchi Y, Suzuki T. Nagao A, et al. Among authors: nakanishi y. Nat Commun. 2023 May 17;14(1):2704. doi: 10.1038/s41467-023-38077-5. Nat Commun. 2023. PMID: 37198183 Free PMC article.
Application of model-informed drug development (MIDD) for dose selection in regulatory submissions for drug approval in Japan.
JPMA MIDD Task force; Sasaki T, Katsube T, Hayato S, Yamaguchi S, Tanaka J, Yoshimatsu H, Nakanishi Y, Kitamura A, Watase H, Suganami H, Matsuoka N, Hasegawa C. JPMA MIDD Task force, et al. Among authors: nakanishi y. J Pharmacokinet Pharmacodyn. 2025 Jan 6;52(1):10. doi: 10.1007/s10928-024-09954-3. J Pharmacokinet Pharmacodyn. 2025. PMID: 39762622
Survivin as a therapeutic target for neuroendocrine neoplasms.
Hane Y, Tsuchikawa T, Nakamura T, Hatanaka KC, Sasaki K, Kawai N, Takeuchi S, Tanaka K, Nakanishi Y, Asano T, Noji T, Shichinohe T, Hatanaka Y, Hirohshi Y, Torigoe T, Hirano S. Hane Y, et al. Among authors: nakanishi y. Neuroendocrinology. 2025 Jan 2:1-31. doi: 10.1159/000543270. Online ahead of print. Neuroendocrinology. 2025. PMID: 39746333
Cholangiocyte organoids for disease, cancer, and regenerative medicine.
Nagao M, Fukuda A, Kashima H, Matsuyama S, Iimori K, Nakayama S, Mizukoshi K, Kawai M, Yamakawa G, Omatsu M, Namikawa M, Masuda T, Hiramatsu Y, Muta Y, Maruno T, Nakanishi Y, Tsuruyama T, Seno H. Nagao M, et al. Among authors: nakanishi y. Eur J Cell Biol. 2024 Dec 19;104(1):151472. doi: 10.1016/j.ejcb.2024.151472. Online ahead of print. Eur J Cell Biol. 2024. PMID: 39721346 Free article.
2,336 results